New York Demo Day June 29th; San Francisco early applications due June 30th

Learn more about investing in Biomage

Our team will get back to you soon to follow up on your inquiry.
Lead Rounds?
Biomage
From single-cell data to biological insights
Founded
2019
Employees*
1-10
Funding to Date*
$1.8M
Website
biomage.net
Adam Kurkiewicz, PhD, CEO
Scientists need excellent software. It’s often treated as an afterthought or something that is only a small part of research grants.
Biomage turns meaningful insights from single-cell RNA sequencing from a 3-6 month project into a 1-2 week process, saving time, money, and labor.

Single cell RNA-seq can be used to look at major genetic pathways across multiple cell types (e.g. different types of neurons or blood cells). Its many uses include searching for off-target effects of the lead candidate drug or identifying heterogeneous subclones within a tumour to create predictive models of response to different chemotherapeutics.

Biomage’s product, Cellscope, allows biologists with no prior bioinformatics training to analyse large, multi-sample single cell RNA-seq datasets, perform data integration and execute differential analysis of specific pathways.